Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Melanocortin 4 receptors switch reward to aversion
Alexandra G. DiFeliceantonio, Paul J. Kenny
Alexandra G. DiFeliceantonio, Paul J. Kenny
Published June 18, 2018
Citation Information: J Clin Invest. 2018;128(7):2757-2759. https://doi.org/10.1172/JCI121653.
View: Text | PDF
Commentary Article has an altmetric score of 1

Melanocortin 4 receptors switch reward to aversion

  • Text
  • PDF
Abstract

The ability to recognize and avoid noxious stimuli is essential for survival. The factors that determine whether a given stimulus is considered positive or negative are complex and not fully understood. In this issue of the JCI, Klawonn and colleagues demonstrate that melanocortin 4 receptor (MC4R) signaling is critical for proper responses to negative stimuli. Mice lacking MC4R were shown to have a surprising preference for aversive stimuli compared with WT animals. Moreover, the authors provide evidence that avoidance behaviors are mediated by hypothalamic POMC neurons signaling to striatal dopamine D1 receptor–expressing medium spiny neurons. Together, these results provide important insight into the regulation of responses to aversive stimuli.

Authors

Alexandra G. DiFeliceantonio, Paul J. Kenny

×

Figure 1

POMC neurons act through MC4R receptors in striatum to control avoidance behavior.

Options: View larger image (or click on image) Download as PowerPoint
POMC neurons act through MC4R receptors in striatum to control avoidance...
POMC-producing neurons in arcuate nucleus are activated by noxious stimuli. These neurons project to the striatum, where they activate D1R-expressing MSNs through MC4Rs. These D1R-expressing cells are likely those that project to the midbrain to inhibit dopamine neurons. In the absence of MC4R signaling, POMC neurons do not activate D1R-expressing MSNs in striatum. This results in disinhibited dopamine transmission and the formation of maladaptive positive associations between noxious stimuli and the environments in which they are encountered. DA, dopamine.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
19 readers on Mendeley
See more details